Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.0
85.79%
80%
—
-63.90%
60%
—
5 Years
Score6.0
Net Growth85.79%
Net Trend80%
Net Income Consistency—
Rev Growth-63.90%
Rev Trend60%
Revenue Consistency—
Novavax Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 475M to $ 1.12B and net income went from -$ 427M to $ 440M. Revenue increased in 3 of those 5 years; net income in 4.
Between 2015 and 2025, revenue grew from $ 36M to $ 1.12B and net income went from -$ 156M to $ 440M. Revenue increased in 7 of those 10 years; net income in 6.
Novavax Inc currently holds a 20-year HDB Score of 3.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 7.96 | — |
1 Year2025-08-12 | $ 8.48 | -6.13% |
5 Years2021-08-12 | $ 247.24 | -96.78% |
10 Years2016-08-12 | $ 140.80 | -94.35% |
20 Years2006-08-11 | $ 62.20 | -87.20% |
30 Years1996-08-12 | $ 81.25 | -90.20% |
All Time1995-12-05 | $ 80.00 | -90.05% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1995-12-05 |
|---|---|---|---|---|---|---|---|
| Price | $ 7.96 | $ 8.48 | $ 247.24 | $ 140.80 | $ 62.20 | $ 81.25 | $ 80.00 |
| Return | — | -6.13% | -96.78% | -94.35% | -87.20% | -90.20% | -90.05% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 413M | -$ 247M | $ 719M |
| 2025 | $ 1.12B | $ 440M | $ 735M |
| 2024 | $ 682M | -$ 187M | $ 923M |
| 2023 | $ 556M | -$ 545M | $ 568M |
| 2022 | $ 1.59B | -$ 657M | $ 1.33B |
| 2021 | $ 1.14B | -$ 1.74B | $ 1.51B |
| 2020 | $ 475M | -$ 427M | $ 711M |
| 2019 | $ 18M | -$ 130M | $ 78M |
| 2018 | $ 34M | -$ 184M | $ 70M |
| 2017 | $ 31M | -$ 183M | $ 106M |
| 2016 | $ 15M | -$ 279M | $ 144M |
| 2015 | $ 36M | -$ 156M | $ 230M |
| 2014 | $ 30M | -$ 82M | $ 168M |
| 2013 | $ 20M | -$ 51M | $ 133M |
| 2012 | $ 22M | -$ 28M | $ 44M |
| 2011 | $ 14M | -$ 19M | $ 18M |
| 2010 | $ 343K | -$ 35M | $ 31M |
| 2009 | $ 325K | -$ 38M | $ 42M |
| 2008 | $ 1M | -$ 36M | $ 33M |
| 2007 | $ 1M | -$ 34M | $ 46M |
| 2006 | $ 4M | -$ 23M | $ 73M |
| 2005 | $ 7M | -$ 11M | $ 31M |
| 2004 | $ 8M | -$ 25M | $ 17M |
| 2003 | $ 11M | -$ 17M | $ 27M |
| 2002 | $ 15M | -$ 22M | $ 3M |
| 2001 | $ 24M | -$ 9M | $ 20M |
| 2000 | $ 2M | -$ 12M | $ 14M |
| 1999 | $ 1M | -$ 4M | $ 700K |
| 1998 | $ 700K | -$ 4M | $ 1M |
| 1997 | $ 500K | -$ 4M | $ 3M |
| 1996 | $ 100K | -$ 5M | $ 2M |
Explore beyond NVAX
You're looking at Novavax Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
